{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T16:32:01Z","timestamp":1794501121969,"version":"4.9.1"},"reference-count":266,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":320,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1186\/s13613-025-01479-3","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T03:08:33Z","timestamp":1748488113000},"page":"74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Guidelines for the management of emergencies and critical illness in pediatric and adult patients with sickle cell disease"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5961-5577","authenticated-orcid":false,"given":"Armand","family":"Mekontso Dessap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Dauger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Khellaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maite","family":"Agbakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Agut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Angoulvant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Beno\u00eet","family":"Arlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Aubron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Baudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Boissier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Bounaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Catoire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Cecchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djamila","family":"Chaiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Chauvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Chocron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte","family":"Douay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Douillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narcisse","family":"Elenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Flechelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9gol\u00e8ne","family":"Gendreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sybille","family":"Goddet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Guenezan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoosha","family":"Habibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Heilbronner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9reng\u00e8re","family":"Koehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierrick","family":"Le Borgne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Le Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"Legras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Maitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Oberlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Oualha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Peschanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"France","family":"Pirenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Pondarre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Rambaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyvan","family":"Razazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffroy","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Schirmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Thuret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruddy","family":"Valentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Voiriot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Villoing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Grimaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Jean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1186\/s13613-025-01479-3_bb0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ajh.21569","article-title":"Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease","volume":"85","author":"Fitzhugh","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1186\/s13613-025-01479-3_bb0015","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00134-016-4472-7","article-title":"Ten tips for managing critically ill patients with sickle cell disease","volume":"43","author":"Mekontso Dessap","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1186\/s13613-025-01479-3_bb0020","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1097\/CCM.0000000000000316","article-title":"Outcomes of adult patients with sickle cell disease admitted to the ICU: a case series*","volume":"42","author":"Cecchini","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1186\/s13613-025-01479-3_bb0025","doi-asserted-by":"crossref","first-page":"23132","DOI":"10.1038\/s41598-021-02437-2","article-title":"Nationwide retrospective study of critically ill adults with sickle cell disease in France","volume":"11","author":"Agbakou","year":"2021","journal-title":"Sci Rep"},{"key":"10.1186\/s13613-025-01479-3_bb0030","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1038\/s41598-023-32651-z","article-title":"Multi-center retrospective study of children with sickle cell disease admitted to pediatric intensive care units in the United States","volume":"13","author":"Ettinger","year":"2023","journal-title":"Sci Rep"},{"key":"10.1186\/s13613-025-01479-3_bb0035","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1365-2141.2010.08272.x","article-title":"Outcome of children with sickle cell disease admitted to intensive care - a single institution experience","volume":"150","author":"Bartram","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1186\/s13613-025-01479-3_bb0040","first-page":"801","article-title":"Factors associated with mechanical ventilation use in children with sickle cell disease and acute chest syndrome","volume":"19","author":"Takahashi","year":"2018","journal-title":"Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc"},{"key":"10.1186\/s13613-025-01479-3_bb0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.anpedi.2021.06.005","article-title":"Sickle cell disease in pediatric intensive care","volume":"97","author":"Cieza-Asenjo","year":"2022","journal-title":"An Pediatr"},{"key":"10.1186\/s13613-025-01479-3_bb0050","article-title":"Pediatric sickle cell disease and stroke: a literature review","volume":"15","author":"Parikh","year":"2023","journal-title":"Cureus"},{"key":"10.1186\/s13613-025-01479-3_bb0055","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/pbc.21537","article-title":"Day hospital versus inpatient management of uncomplicated vaso-occlusive crises in children with sickle cell disease","volume":"51","author":"Raphael","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1186\/s13613-025-01479-3_bb0060","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/bjh.16002","article-title":"Management of vaso-occlusive episodes in the day hospital decreases admissions in children with sickle cell disease","volume":"186","author":"Karkoska","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1186\/s13613-025-01479-3_bb0065","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.jpeds.2015.09.007","article-title":"Association between hospital volume and within-hospital intensive care unit transfer for sickle cell disease in children\u2019s hospitals","volume":"167","author":"Raphael","year":"2015","journal-title":"J Pediatr"},{"key":"10.1186\/s13613-025-01479-3_bb0070","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1542\/peds.2013-0089","article-title":"Association of hospital and provider types on sickle cell disease outcomes","volume":"132","author":"Jan","year":"2013","journal-title":"Pediatrics"},{"key":"10.1186\/s13613-025-01479-3_bb0075","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"key":"10.1186\/s13613-025-01479-3_bb0080","first-page":"680","article-title":"Fentanyl buccal tablet: a new breakthrough pain medication in early management of severe vaso-occlusive crisis in sickle cell disease","volume":"16","author":"De Franceschi","year":"2016","journal-title":"Pain Pract Off J World Inst Pain"},{"key":"10.1186\/s13613-025-01479-3_bb0085","doi-asserted-by":"crossref","first-page":"e1016","DOI":"10.1542\/peds.2014-3470","article-title":"Improving the Management of vaso-occlusive episodes in the pediatric emergency department","volume":"136","author":"Kavanagh","year":"2015","journal-title":"Pediatrics"},{"key":"10.1186\/s13613-025-01479-3_bb0090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ajh.24948","article-title":"A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD)","volume":"93","author":"Tanabe","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1186\/s13613-025-01479-3_bb0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/20494637211033814","article-title":"A non-injected opioid analgesia protocol for acute pain crisis in adolescents and adults with sickle cell disease","volume":"16","author":"Telfer","year":"2022","journal-title":"Br J Pain"},{"key":"10.1186\/s13613-025-01479-3_bb0100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4103\/sja.SJA_228_17","article-title":"Assessment of patient-controlled analgesia versus intermittent opioid therapy to manage sickle-cell disease vaso-occlusive crisis in adult patients","volume":"11","author":"Al-Anazi","year":"2017","journal-title":"Saudi J Anaesth"},{"key":"10.1186\/s13613-025-01479-3_bb0105","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archinte.1991.00400070131017","article-title":"Intermittent injection vs patient-controlled analgesia for sickle cell crisis pain. Comparison in patients in the emergency department","volume":"151","author":"Gonzalez","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1186\/s13613-025-01479-3_bb0110","doi-asserted-by":"crossref","first-page":"46","DOI":"10.14740\/jh828","article-title":"Opioid use in adults with sickle cell disease hospitalized during vaso-occlusive crisis: a systematic review","volume":"10","author":"Osborne","year":"2021","journal-title":"J Hematol"},{"key":"10.1186\/s13613-025-01479-3_bb0115","doi-asserted-by":"crossref","first-page":"3218186","DOI":"10.1155\/2016\/3218186","article-title":"Patient controlled analgesia for adults with sickle cell disease awaiting admission from the emergency department","volume":"2016","author":"Santos","year":"2016","journal-title":"Pain Res Manag"},{"key":"10.1186\/s13613-025-01479-3_bb0120","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/ajh.20944","article-title":"Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial","volume":"82","author":"van Beers","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1186\/s13613-025-01479-3_bb0125","article-title":"Adjuvant analgesic use in the critically ill: a systematic review and meta-analysis","volume":"2","author":"Wheeler","year":"2020","journal-title":"Crit Care Explor"},{"key":"10.1186\/s13613-025-01479-3_bb0130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ajh.2830460108","article-title":"Enhancement of pain control with ketorolac tromethamine in patients with sickle cell vaso-occlusive crisis","volume":"46","author":"Perlin","year":"1994","journal-title":"Am J Hematol"},{"key":"10.1186\/s13613-025-01479-3_bb0135","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0196-0644(05)82929-4","article-title":"Ketorolac for sickle cell vaso-occlusive crisis pain in the emergency department: lack of a narcotic-sparing effect","volume":"21","author":"Wright","year":"1992","journal-title":"Ann Emerg Med"},{"key":"10.1186\/s13613-025-01479-3_bb0140","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1182\/blood-2009-06-227330","article-title":"A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults","volume":"114","author":"Bartolucci","year":"2009","journal-title":"Blood"},{"key":"10.1186\/s13613-025-01479-3_bb0145","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/bloodadvances.2020001851","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain","volume":"4","author":"Brandow","year":"2020","journal-title":"Blood Adv"},{"key":"10.1186\/s13613-025-01479-3_bb0150","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/jcpt.12592","article-title":"Use of anti-inflammatory analgesics in sickle-cell disease","volume":"42","author":"Han","year":"2017","journal-title":"J Clin Pharm Ther"},{"key":"10.1186\/s13613-025-01479-3_bb0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/sjmms.sjmms_218_20","article-title":"Ketamine for sickle cell vaso-occlusive crises: a systematic review","volume":"9","author":"Alshahrani","year":"2021","journal-title":"Saudi J Med Med Sci"},{"key":"10.1186\/s13613-025-01479-3_bb0160","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.ajem.2017.03.004","article-title":"A prospective randomized, double-dummy trial comparing IV push low dose ketamine to short infusion of low dose ketamine for treatment of pain in the ED","volume":"35","author":"Motov","year":"2017","journal-title":"Am J Emerg Med"},{"key":"10.1186\/s13613-025-01479-3_bb0165","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/cpt.2149","article-title":"Clinical pharmacogenetics implementation consortium guideline for CYP2D6, OPRM1, and COMT genotypes and select opioid therapy","volume":"110","author":"Crews","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1186\/s13613-025-01479-3_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248649","article-title":"Descriptive analysis of sickle cell patients living in France: The PHEDRE cross-sectional study","volume":"16","author":"Gerardin","year":"2021","journal-title":"PLoS ONE"},{"key":"10.1186\/s13613-025-01479-3_bb0175","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Patient et professionnels de sant\u00e9 : d\u00e9cider ensemble [Internet]. Haute Aut. Sant\u00e9. 2023 [cited 2023 Oct 26]. https:\/\/www.has-sante.fr\/jcms\/c_1671523\/fr\/patient-et-professionnels-de-sante-decider-ensemble"},{"key":"10.1186\/s13613-025-01479-3_bb0180","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/bjh.16015","article-title":"Development and validation of the Satisfaction with Treatment for Pain Questionnaire (STPQ) among patients with sickle cell disease","volume":"187","author":"Elander","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1186\/s13613-025-01479-3_bb0185","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.annemergmed.2013.02.004","article-title":"Emergency provider analgesic practices and attitudes toward patients with sickle cell disease","volume":"62","author":"Glassberg","year":"2013","journal-title":"Ann Emerg Med"},{"key":"10.1186\/s13613-025-01479-3_bb0190","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.pmn.2016.05.001","article-title":"Does attendance at a sickle cell educational conference improve clinician knowledge and attitude toward patients with sickle cell disease?","volume":"17","author":"Jenerette","year":"2016","journal-title":"Pain Manag Nurs Off J Am Soc Pain Manag Nurses"},{"key":"10.1186\/s13613-025-01479-3_bb0195","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/082585970502100403","article-title":"Physicians\u2019 attitude and practices in sickle cell disease pain management","volume":"21","author":"Labb\u00e9","year":"2005","journal-title":"J Palliat Care"},{"key":"10.1186\/s13613-025-01479-3_bb0200","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0885-3924(97)00019-5","article-title":"Sickle cell-related pain: perceptions of medical practitioners","volume":"14","author":"Shapiro","year":"1997","journal-title":"J Pain Symptom Manage"},{"key":"10.1186\/s13613-025-01479-3_bb0205","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jpain.2010.10.012","article-title":"Increased clearance of morphine in sickle cell disease: implications for pain management","volume":"12","author":"Darbari","year":"2011","journal-title":"J Pain"},{"key":"10.1186\/s13613-025-01479-3_bb0210","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/acem.14149","article-title":"Does intravenous acetaminophen reduce opioid requirement in pediatric emergency department patients with acute sickle cell crises?","volume":"28","author":"Dhebaria","year":"2021","journal-title":"Acad Emerg Med Off J Soc Acad Emerg Med"},{"key":"10.1186\/s13613-025-01479-3_bb0215","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00006565-199906000-00004","article-title":"Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis","volume":"15","author":"Hardwick","year":"1999","journal-title":"Pediatr Emerg Care"},{"key":"10.1186\/s13613-025-01479-3_bb0220","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-3156.2000.00507.x","article-title":"An open comparative study of dispersible piroxicam versus soluble acetylsalicylic acid for the treatment of osteoarticular painful attack during sickle cell crisis","volume":"5","author":"Eke","year":"2000","journal-title":"Trop Med Int Health TM IH"},{"key":"10.1186\/s13613-025-01479-3_bb0225","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1001\/archpedi.155.4.496","article-title":"Intravenous ketorolac in the emergency department management of sickle cell pain and predictors of its effectiveness","volume":"155","author":"Beiter","year":"2001","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1186\/s13613-025-01479-3_bb0230","first-page":"90","article-title":"Efficacy of nalbuphine as a parenteral analgesic for the treatment of painful episodes in children with sickle cell disease","volume":"1","author":"Woods","year":"1990","journal-title":"J Assoc Acad Minor Physicians Off Publ Assoc Acad Minor Physicians"},{"key":"10.1186\/s13613-025-01479-3_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27420","article-title":"Impact of early analgesia on hospitalization outcomes for sickle cell pain crisis","volume":"65","author":"Payne","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1186\/s13613-025-01479-3_bb0240","first-page":"615","article-title":"Evaluation of vaso-occlusive crisis management with patient-controlled analgesia in children with sickle cell disease requiring hospitalization","volume":"26","author":"Arbitre","year":"2021","journal-title":"J Pediatr Pharmacol Ther JPPT Off J PPAG"},{"key":"10.1186\/s13613-025-01479-3_bb0245","first-page":"179","article-title":"Analgesic response to morphine in children with sickle cell disease: a pilot study","volume":"2","author":"Jacob","year":"2008","journal-title":"J Pain Manag"},{"key":"10.1186\/s13613-025-01479-3_bb0250","doi-asserted-by":"crossref","first-page":"E70","DOI":"10.1002\/ajh.22176","article-title":"Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodes","volume":"86","author":"Dampier","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1186\/s13613-025-01479-3_bb0255","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0882-5963(98)80064-X","article-title":"A comparison of two regimens of patient-controlled analgesia for children with sickle cell disease","volume":"13","author":"Trentadue","year":"1998","journal-title":"J Pediatr Nurs"},{"key":"10.1186\/s13613-025-01479-3_bb0260","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/ajh.24534","article-title":"Impact of emergency department care on outcomes of acute pain events in children with sickle cell disease","volume":"91","author":"Brandow","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1186\/s13613-025-01479-3_bb0265","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1542\/peds.2014-2874","article-title":"Timing of opioid administration as a quality indicator for pain crises in sickle cell disease","volume":"135","author":"Mathias","year":"2015","journal-title":"Pediatrics"},{"key":"10.1186\/s13613-025-01479-3_bb0270","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26332","article-title":"Intranasal fentanyl for initial treatment of vaso-occlusive crisis in sickle cell disease","author":"Fein","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"10.1186\/s13613-025-01479-3_bb0275","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/pch\/pxz022","article-title":"Evaluation of a clinical protocol using intranasal fentanyl for treatment of vaso-occlusive crisis in sickle cell patients in the emergency department","volume":"25","author":"Paquin","year":"2020","journal-title":"Paediatr Child Health"},{"key":"10.1186\/s13613-025-01479-3_bb0280","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.25144","article-title":"Impact of intranasal fentanyl in nurse initiated protocols for sickle cell vaso-occlusive pain episodes in a pediatric emergency department","author":"Akinsola","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1186\/s13613-025-01479-3_bb0285","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.ajem.2017.11.015","article-title":"Intranasal fentanyl improves time to analgesic delivery in sickle cell pain crises","volume":"36","author":"Kelly","year":"2018","journal-title":"Am J Emerg Med"},{"key":"10.1186\/s13613-025-01479-3_bb0290","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(97)08462-6","article-title":"Randomised trial of oral morphine for painful episodes of sickle-cell disease in children","volume":"350","author":"Jacobson","year":"1997","journal-title":"Lancet Lond Engl"},{"key":"10.1186\/s13613-025-01479-3_bb0295","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/pch\/pxy074","article-title":"Oral morphine protocol evaluation for the treatment of vaso-occlusive crisis in paediatric sickle cell patients","volume":"24","author":"Paquin","year":"2019","journal-title":"Paediatr Child Health"},{"issue":"45","key":"10.1186\/s13613-025-01479-3_bb0300","first-page":"33","article-title":"Oral morphine protocol for sickle cell crisis pain","volume":"1996","author":"Conti","year":"1985","journal-title":"Md Med J Baltim Md"},{"key":"10.1186\/s13613-025-01479-3_bb0305","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1515\/sjpain-2017-0140","article-title":"Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial","volume":"18","author":"Lubega","year":"2018","journal-title":"Scand J Pain"},{"key":"10.1186\/s13613-025-01479-3_bb0310","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/AJP.0b013e3181b511ab","article-title":"Use of low-dose ketamine infusion for pediatric patients with sickle cell disease-related pain: a case series","volume":"26","author":"Zempsky","year":"2010","journal-title":"Clin J Pain"},{"key":"10.1186\/s13613-025-01479-3_bb0315","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2147\/JPR.S131156","article-title":"Subanesthetic ketamine for pain management in hospitalized children, adolescents, and young adults: a single-center cohort study","volume":"10","author":"Sheehy","year":"2017","journal-title":"J Pain Res"},{"key":"10.1186\/s13613-025-01479-3_bb0320","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/SPC.0000000000000437","article-title":"Ketamine and lidocaine infusions decrease opioid consumption during vaso-occlusive crisis in adolescents with sickle cell disease","volume":"13","author":"Puri","year":"2019","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1186\/s13613-025-01479-3_bb0325","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1097\/MPH.0000000000002290","article-title":"Low-dose ketamine infusion for pediatric hematology\/oncology patients: case series and literature review","volume":"44","author":"Yu","year":"2022","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1186\/s13613-025-01479-3_bb0330","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/jama.289.9.1136","article-title":"Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease","volume":"289","author":"Weiner","year":"2003","journal-title":"JAMA"},{"key":"10.1186\/s13613-025-01479-3_bb0335","first-page":"CD011808","article-title":"Inhaled nitric oxide for treating pain crises in people with sickle cell disease","volume":"7","author":"Aboursheid","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1186\/s13613-025-01479-3_bb0340","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30315","article-title":"Efficacy of non-pharmacological interventions to reduce pain in children with sickle cell disease: a systematic review","volume":"70","author":"van Veelen","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"10.1186\/s13613-025-01479-3_bb0345","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27525","article-title":"Virtual reality as complementary pain therapy in hospitalized patients with sickle cell disease","volume":"66","author":"Agrawal","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"10.1186\/s13613-025-01479-3_bb0350","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jpainsymman.2016.12.351","article-title":"A randomized trial of yoga for children hospitalized with sickle cell vaso-occlusive crisis","volume":"53","author":"Moody","year":"2017","journal-title":"J Pain Symptom Manage"},{"key":"10.1186\/s13613-025-01479-3_bb0355","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0038-0814(20)30115-8","article-title":"Baeza-Velasco C [Effects of a standardized musical intervention on the management of pain and anxiety-state of sickle-cell adolescents]","volume":"41","author":"Martin","year":"2020","journal-title":"Soins Pediatr Pueric"},{"key":"10.1186\/s13613-025-01479-3_bb0360","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000205612","article-title":"Transcutaneous electrical nerve stimulation treatment of sickle cell pain crises","volume":"80","author":"Wang","year":"1988","journal-title":"Acta Haematol"},{"key":"10.1186\/s13613-025-01479-3_bb0365","doi-asserted-by":"crossref","first-page":"e1634","DOI":"10.1542\/peds.2013-2065","article-title":"Intravenous magnesium sulfate for vaso-occlusive episodes in sickle cell disease","volume":"132","author":"Goldman","year":"2013","journal-title":"Pediatrics"},{"key":"10.1186\/s13613-025-01479-3_bb0370","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1182\/blood-2015-05-647107","article-title":"A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children","volume":"126","author":"Brousseau","year":"2015","journal-title":"Blood"},{"key":"10.1186\/s13613-025-01479-3_bb0375","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM199403173301101","article-title":"High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease","volume":"330","author":"Griffin","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1186\/s13613-025-01479-3_bb0380","first-page":"312","article-title":"Evaluation of individualized pain plans for children with sickle cell disease admitted for vaso-occlusive crisis at riley hospital for children","volume":"27","author":"Arends","year":"2022","journal-title":"J Pediatr Pharmacol Ther JPPT Off J PPAG"},{"key":"10.1186\/s13613-025-01479-3_bb0385","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1182\/blood-2002-05-1392","article-title":"Nocturnal oxygen saturation and painful sickle cell crises in children","volume":"101","author":"Hargrave","year":"2003","journal-title":"Blood"},{"key":"10.1186\/s13613-025-01479-3_bb0390","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1182\/blood.V86.10.3998.bloodjournal86103998","article-title":"Oxygen inhalation in nonhypoxic sickle cell patients during vaso-occlusive crisis","volume":"86","author":"Khoury","year":"1995","journal-title":"Blood"},{"key":"10.1186\/s13613-025-01479-3_bb0395","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/08880019209016603","article-title":"Analgesia in children with sickle cell crisis: comparison of intermittent opioids vs. continuous intravenous infusion of morphine and placebo-controlled study of oxygen inhalation","volume":"9","author":"Robieux","year":"1992","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1186\/s13613-025-01479-3_bb0400","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00043426-199208000-00007","article-title":"Oxygen therapy in sickle cell disease","volume":"14","author":"Zipursky","year":"1992","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1186\/s13613-025-01479-3_bb0405","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1600-0609.2004.00396.x","article-title":"Hemoglobin oxygen saturation discrepancy using various methods in patients with sickle cell vaso-occlusive painful crisis","volume":"74","author":"Ahmed","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1186\/s13613-025-01479-3_bb0410","unstructured":"ALD n\u00b0 10 - Syndromes dr\u00e9panocytaires majeurs de l\u2019enfant et de l\u2019adolescent [Internet]. Haute Aut. Sant\u00e9. [cited 2023 Oct 9]. https:\/\/www.has-sante.fr\/jcms\/c_938890\/fr\/ald-n-10-syndromes-drepanocytaires-majeurs-de-l-enfant-et-de-l-adolescent."},{"key":"10.1186\/s13613-025-01479-3_bb0415","unstructured":"Overview | Sickle cell disease: managing acute painful episodes in hospital | Guidance | NICE [Internet]. NICE; 2012 [cited 2023 Oct 9]. https:\/\/www.nice.org.uk\/guidance\/cg143"},{"key":"10.1186\/s13613-025-01479-3_bb0420","doi-asserted-by":"crossref","unstructured":"Habibi A, Arlet J-B, Stankovic K, Gellen-Dautremer J, Ribeil J-A, Bartolucci P, et al. [French guidelines for the management of adult sickle cell disease: 2015 update]. Rev M\u00e9decine Interne Fond\u00e9e Par Soci\u00e9t\u00e9 Natl Francaise M\u00e9decine Interne. 2015;36:5S3\u201384.","DOI":"10.1016\/S0248-8663(15)60002-9"},{"key":"10.1186\/s13613-025-01479-3_bb0425","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/ped.2017.0814","article-title":"Acute chest syndrome in children with sickle cell disease","volume":"30","author":"Jain","year":"2017","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"key":"10.1186\/s13613-025-01479-3_bb0430","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM199509143331104","article-title":"Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases","volume":"333","author":"Bellet","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1186\/s13613-025-01479-3_bb0435","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/MPH.0b013e31821ed4ce","article-title":"The use of incentive spirometry in pediatric patients with sickle cell disease to reduce the incidence of acute chest syndrome","volume":"33","author":"Ahmad","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1186\/s13613-025-01479-3_bb0440","doi-asserted-by":"crossref","first-page":"e480","DOI":"10.1542\/peds.2010-3099","article-title":"Improving care for children with sickle cell disease\/acute chest syndrome","volume":"127","author":"Crabtree","year":"2011","journal-title":"Pediatrics"},{"key":"10.1186\/s13613-025-01479-3_bb0445","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/bjh.13348","article-title":"Guideline on the management of acute chest syndrome in sickle cell disease","volume":"169","author":"Howard","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1186\/s13613-025-01479-3_bb0450","doi-asserted-by":"crossref","first-page":"624","DOI":"10.4187\/respcare.05500624","article-title":"Positive expiratory pressure device acceptance by hospitalized children with sickle cell disease is comparable to incentive spirometry","volume":"50","author":"Hsu","year":"2005","journal-title":"Respir Care"},{"key":"10.1186\/s13613-025-01479-3_bb0455","doi-asserted-by":"crossref","first-page":"E160","DOI":"10.1002\/ajh.25805","article-title":"Incentive spirometry to prevent acute chest syndrome in adults with sickle cell disease; a randomized controlled trial","volume":"95","author":"van Tuijn","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1186\/s13613-025-01479-3_bb0460","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ajh.22265","article-title":"Inpatient management of sickle cell pain: a \u201csnapshot\u201d of current practice","volume":"87","author":"Miller","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1186\/s13613-025-01479-3_bb0465","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ebiom.2016.06.038","article-title":"Score predicting acute chest syndrome during vaso-occlusive crises in adult sickle-cell disease patients","volume":"10","author":"Bartolucci","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1186\/s13613-025-01479-3_bb0470","article-title":"Microfluidics in sickle cell disease research: state of the art and a perspective beyond the flow problem","volume":"7","author":"Aich","year":"2020","journal-title":"Front Mol Biosci"},{"key":"10.1186\/s13613-025-01479-3_bb0475","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.blre.2015.08.005","article-title":"The role of blood rheology in sickle cell disease","volume":"30","author":"Connes","year":"2016","journal-title":"Blood Rev"},{"key":"10.1186\/s13613-025-01479-3_bb0480","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1182\/blood-2017-04-780635","article-title":"Extracellular fluid tonicity impacts sickle red blood cell deformability and adhesion","volume":"130","author":"Carden","year":"2017","journal-title":"Blood"},{"key":"10.1186\/s13613-025-01479-3_bb0485","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/asheducation-2017.1.435","article-title":"Chronic organ failure in adult sickle cell disease","volume":"2017","author":"Vichinsky","year":"2017","journal-title":"Hematology"},{"issue":"7","key":"10.1186\/s13613-025-01479-3_bb0490","first-page":"CD005406","article-title":"Fluid replacement therapy for acute episodes of pain in people with sickle cell disease","volume":"7","author":"Okomo","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1186\/s13613-025-01479-3_bb0495","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/S0140-6736(16)00647-4","article-title":"Cardiovascular complications and risk of death in sickle-cell disease","volume":"387","author":"Gladwin","year":"2016","journal-title":"The Lancet"},{"key":"10.1186\/s13613-025-01479-3_bb0500","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s00277-020-04050-1","article-title":"Outcomes related to intravenous fluid administration in sickle cell patients during vaso-occlusive crisis","volume":"99","author":"Gaut","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1186\/s13613-025-01479-3_bb0505","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/bjh.17696","article-title":"Fluid overload due to intravenous fluid therapy for vaso-occlusive crisis in sickle cell disease: incidence and risk factors","volume":"194","author":"Gaartman","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1186\/s13613-025-01479-3_bb0510","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26742","article-title":"Variations in pediatric emergency medicine physician practices for intravenous fluid management in children with sickle cell disease and vaso-occlusive pain: a single institution experience","author":"Carden","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1186\/s13613-025-01479-3_bb0515","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00134-022-06882-z","article-title":"ESPNIC clinical practice guidelines: intravenous maintenance fluid therapy in acute and critically ill children- a systematic review and meta-analysis","volume":"48","author":"Brossier","year":"2022","journal-title":"Intensive Care Med"},{"key":"10.1186\/s13613-025-01479-3_bb0520","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.ajem.2018.07.006","article-title":"Bedside ultrasound as a predictive tool for acute chest syndrome in sickle cell patients","volume":"36","author":"Colla","year":"2018","journal-title":"Am J Emerg Med"},{"key":"10.1186\/s13613-025-01479-3_bb0525","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002553","article-title":"Bedside lung ultrasound during acute chest syndrome in sickle cell disease","volume":"95","author":"Razazi","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1186\/s13613-025-01479-3_bb0530","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/acem.13002","article-title":"Accuracy of point-of-care lung ultrasonography for diagnosis of acute chest syndrome in pediatric patients with sickle cell disease and fever","volume":"23","author":"Daswani","year":"2016","journal-title":"Acad Emerg Med Off J Soc Acad Emerg Med"},{"key":"10.1186\/s13613-025-01479-3_bb0535","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.annemergmed.2020.08.012","article-title":"Utility of point-of-care lung ultrasonography for evaluating acute chest syndrome in young patients with sickle cell disease","volume":"76","author":"Cohen","year":"2020","journal-title":"Ann Emerg Med"},{"key":"10.1186\/s13613-025-01479-3_bb0540","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29283","article-title":"Point-of-care lung ultrasound is more reliable than chest X-ray for ruling out acute chest syndrome in sickle cell pediatric patients: a prospective study","volume":"69","author":"Preto-Zamperlini","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"10.1186\/s13613-025-01479-3_bb0545","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejrad.2018.11.033","article-title":"Sickle cell disease and venous thromboembolism: a retrospective comparison of the rate of positive CT pulmonary angiography in the emergency department","volume":"110","author":"Bates","year":"2019","journal-title":"Eur J Radiol"},{"key":"10.1186\/s13613-025-01479-3_bb0550","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/bjh.14655","article-title":"Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality","volume":"178","author":"Brunson","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1186\/s13613-025-01479-3_bb0555","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s11239-013-0895-y","article-title":"Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know","volume":"35","author":"Naik","year":"2013","journal-title":"J Thromb Thrombolysis"},{"key":"10.1186\/s13613-025-01479-3_bb0560","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1538-7836.2012.04697.x","article-title":"Pulmonary embolism in sickle cell disease: a case-control study","volume":"10","author":"Novelli","year":"2012","journal-title":"J Thromb Haemost JTH"},{"key":"10.1186\/s13613-025-01479-3_bb0565","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2967\/jnumed.117.205641","article-title":"Imaging for pulmonary embolism in sickle cell disease: a 17-year experience","volume":"59","author":"Tivnan","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1186\/s13613-025-01479-3_bb0570","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1164\/rccm.201105-0783OC","article-title":"Pulmonary artery thrombosis during acute chest syndrome in sickle cell disease","volume":"184","author":"Mekontso Dessap","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1186\/s13613-025-01479-3_bb0575","first-page":"54","volume":"2019","author":"Konstantinides","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1186\/s13613-025-01479-3_bb0580","first-page":"105","article-title":"Elevated fibrin D-dimer fragment in sickle cell anemia: evidence for activation of coagulation during the steady state as well as in painful crisis","volume":"19","author":"Francis","year":"1989","journal-title":"Haemostasis"},{"key":"10.1186\/s13613-025-01479-3_bb0585","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/bjh.14914","article-title":"A clinical risk score for pulmonary artery thrombosis during acute chest syndrome in adult patients with sickle cell disease","volume":"179","author":"Winchenne","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1186\/s13613-025-01479-3_bb0590","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/bjh.17552","article-title":"Which adults with sickle cell disease need an evaluation for pulmonary embolism?","volume":"195","author":"El-Amin","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1186\/s13613-025-01479-3_bb0595","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1182\/bloodadvances.2017012336","article-title":"Prevalence and risk factors for venous thromboembolism in children with sickle cell disease: an administrative database study","volume":"2","author":"Kumar","year":"2018","journal-title":"Blood Adv"},{"key":"10.1186\/s13613-025-01479-3_bb0600","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/08880018.2023.2166634","article-title":"Prevalence and risk factors for pulmonary embolism in pediatric sickle cell disease: a national administrative database study","volume":"40","author":"Bala","year":"2023","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1186\/s13613-025-01479-3_bb0605","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ajh.20118","article-title":"Echocardiographic abnormalities in sickle cell disease","volume":"76","author":"Ahmed","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1186\/s13613-025-01479-3_bb0610","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1007\/s00246-019-02202-3","article-title":"Echocardiographic screening of cardiovascular status in pediatric sickle cell disease","volume":"40","author":"Allen","year":"2019","journal-title":"Pediatr Cardiol"},{"key":"10.1186\/s13613-025-01479-3_bb0615","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12887-020-02143-4","article-title":"Right ventricular function among South East Nigeria children with sickle cell anaemia","volume":"20","author":"Chinawa","year":"2020","journal-title":"BMC Pediatr"},{"key":"10.1186\/s13613-025-01479-3_bb0620","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa035477","article-title":"Pulmonary hypertension as a risk factor for death in patients with sickle cell disease","volume":"350","author":"Gladwin","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1186\/s13613-025-01479-3_bb0625","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/rccm.200710-1606OC","article-title":"Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease","volume":"177","author":"Mekontso Dessap","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1186\/s13613-025-01479-3_bb0630","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/SHK.0000000000000640","article-title":"Pulmonary vascular dysfunction and cor pulmonale during acute respiratory distress syndrome in sicklers","volume":"46","author":"Cecchini","year":"2016","journal-title":"Shock Augusta Ga"},{"key":"10.1186\/s13613-025-01479-3_bb0635","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00134-013-2941-9","article-title":"Prevalence and prognosis of cor pulmonale during protective ventilation for acute respiratory distress syndrome","volume":"39","author":"Boissier","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1186\/s13613-025-01479-3_bb0640","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s00134-015-4141-2","article-title":"Acute cor pulmonale during protective ventilation for acute respiratory distress syndrome: prevalence, predictors, and clinical impact","volume":"42","author":"Mekontso Dessap","year":"2016","journal-title":"Intensive Care Med"},{"key":"10.1186\/s13613-025-01479-3_bb0645","doi-asserted-by":"crossref","first-page":"e1055","DOI":"10.1097\/CCM.0000000000003358","article-title":"Early right ventricular systolic dysfunction and pulmonary hypertension are associated with worse outcomes in pediatric acute respiratory distress syndrome","volume":"46","author":"Himebauch","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1186\/s13613-025-01479-3_bb0650","first-page":"e121","article-title":"New or persistent right ventricular systolic dysfunction is associated with worse outcomes in pediatric acute respiratory distress syndrome","volume":"21","author":"Himebauch","year":"2020","journal-title":"Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc"},{"key":"10.1186\/s13613-025-01479-3_bb0655","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000821","article-title":"Positron emission tomography with 18F-fluorodeoxyglucose in patients with sickle cell acute chest syndrome","volume":"94","author":"de Prost","year":"2015","journal-title":"Med Baltim"},{"key":"10.1186\/s13613-025-01479-3_bb0660","doi-asserted-by":"crossref","first-page":"H2715","DOI":"10.1152\/ajpheart.00986.2004","article-title":"Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice","volume":"288","author":"Belcher","year":"2005","journal-title":"Am J Physiol-Heart Circ Physiol"},{"key":"10.1186\/s13613-025-01479-3_bb0665","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2141.2011.08827.x","article-title":"Tapered oral dexamethasone for the acute chest syndrome of sickle cell disease: short report","volume":"155","author":"Quinn","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1186\/s13613-025-01479-3_bb0670","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1182\/blood.V92.9.3082","article-title":"Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease","volume":"92","author":"Bernini","year":"1998","journal-title":"Blood"},{"key":"10.1186\/s13613-025-01479-3_bb0675","article-title":"Role of steroids in sickle cell patients with acute chest syndrome","volume":"14","author":"Jeyamurugan","year":"2022","journal-title":"Cureus"},{"key":"10.1186\/s13613-025-01479-3_bb0680","doi-asserted-by":"crossref","DOI":"10.1097\/MPH.0b013e3181c29c52","article-title":"A short course of prednisone in the management of acute chest syndrome of sickle cell disease","volume":"32","author":"Kumar","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1186\/s13613-025-01479-3_bb0685","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/MPH.0b013e3181647bb2","article-title":"A single-institution experience with treatment of severe acute chest syndrome: lack of rebound pain with dexamethasone plus transfusion therapy","volume":"30","author":"Isakoff","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1186\/s13613-025-01479-3_bb0690","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ajh.21565","article-title":"Corticosteroids for acute chest syndrome in children with sickle cell disease: variation in use and association with length of stay and readmission","volume":"85","author":"Sobota","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1186\/s13613-025-01479-3_bb0695","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/pbc.21336","article-title":"Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease","volume":"50","author":"Strouse","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1186\/s13613-025-01479-3_bb0700","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1182\/blood-2021-151307","article-title":"Risk of hospitalization for vaso-occlusive episode in patients with sickle cell disease after out-patient exposure to systemic corticosteroids","volume":"138","author":"Walter","year":"2021","journal-title":"Blood"},{"key":"10.1186\/s13613-025-01479-3_bb0705","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3324\/haematol.10800","article-title":"Steroid treatment in children with sickle-cell disease","volume":"92","author":"Couillard","year":"2007","journal-title":"Haematologica"},{"key":"10.1186\/s13613-025-01479-3_bb0710","first-page":"948","article-title":"Severe vaso-occlusive episodes associated with use of systemic corticosteroids in patients with sickle cell disease","volume":"100","author":"Darbari","year":"2008","journal-title":"J Natl Med Assoc"},{"key":"10.1186\/s13613-025-01479-3_bb0715","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.3324\/haematol.2021.280105","article-title":"Effects of corticosteroids in patients with sickle cell disease and acute complications: a systematic review and meta-analysis","volume":"107","author":"Lopinto","year":"2022","journal-title":"Haematologica"},{"key":"10.1186\/s13613-025-01479-3_bb0720","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.transci.2017.08.005","article-title":"Corticosteroid-induced vaso-occlusive events may be prevented by lowering hemoglobin S levels in adults with sickle cell disease","volume":"56","author":"Yeral","year":"2017","journal-title":"Transfus Apher Sci"},{"key":"10.1186\/s13613-025-01479-3_bb0725","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/1817-1737.30358","article-title":"Use of noninvasive positive pressure ventilation during pregnancy: case series","volume":"2","author":"Al-Ansari","year":"2007","journal-title":"Ann Thorac Med"},{"key":"10.1186\/s13613-025-01479-3_bb0730","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1365-2141.2010.08271.x","article-title":"Outcome of adults with sickle cell disease admitted to critical care - experience of a single institution in the UK","volume":"150","author":"Gardner","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1186\/s13613-025-01479-3_bb0735","first-page":"177","article-title":"Adult Sickle Cell Disease: A Five-Year Experience of Intensive Care Management in a University Hospital in Oman","volume":"12","author":"Tawfic","year":"2012","journal-title":"Sultan Qaboos Univ Med J"},{"key":"10.1186\/s13613-025-01479-3_bb0740","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1537-2995.2008.02075.x","article-title":"Exchange versus simple transfusion for acute chest syndrome in sickle cell anemia adults","volume":"49","author":"Turner","year":"2009","journal-title":"Transfusion (Paris)"},{"key":"10.1186\/s13613-025-01479-3_bb0745","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM200006223422502","article-title":"Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study group","volume":"342","author":"Vichinsky","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1186\/s13613-025-01479-3_bb0750","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00134-010-1907-4","article-title":"Early intermittent noninvasive ventilation for acute chest syndrome in adults with sickle cell disease: a pilot study","volume":"36","author":"Fartoukh","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1186\/s13613-025-01479-3_bb0755","doi-asserted-by":"crossref","first-page":"e94387","DOI":"10.1371\/journal.pone.0094387","article-title":"Outcomes of Acute Chest Syndrome in Adult Patients with Sickle Cell Disease: Predictors of Mortality","volume":"9","author":"Allareddy","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1186\/s13613-025-01479-3_bb0760","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00003246-199801000-00034","article-title":"Noninvasive ventilation via bilevel positive airway pressure support in pediatric practice","volume":"26","author":"Padman","year":"1998","journal-title":"Crit Care Med"},{"key":"10.1186\/s13613-025-01479-3_bb0765","first-page":"329","article-title":"Noninvasive positive pressure ventilation: five years of experience in a pediatric intensive care unit","volume":"7","author":"Essouri","year":"2006","journal-title":"Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc"},{"key":"10.1186\/s13613-025-01479-3_bb0770","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29136","article-title":"SNAP: Supportive noninvasive ventilation for acute chest syndrome prevention in children with sickle cell disease","volume":"68","author":"Guenther","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"10.1186\/s13613-025-01479-3_bb0775","first-page":"e235","article-title":"Early noninvasive ventilation and nonroutine transfusion for acute chest syndrome in sickle cell disease in children: a descriptive study","volume":"19","author":"Heilbronner","year":"2018","journal-title":"Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc"},{"key":"10.1186\/s13613-025-01479-3_bb0780","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bcmd.2018.03.001","article-title":"Early initiation of inhaled corticosteroids does not decrease acute chest syndrome morbidity in pediatric patients with sickle cell disease","volume":"71","author":"Leonard","year":"2018","journal-title":"Blood Cells Mol Dis"},{"key":"10.1186\/s13613-025-01479-3_bb0785","first-page":"199","article-title":"The use of bilevel positive airway pressure for the treatment of acute chest syndrome of sickle cell disease","volume":"76","author":"Padman","year":"2004","journal-title":"Del Med J"},{"key":"10.1186\/s13613-025-01479-3_bb0790","first-page":"559","article-title":"Therapeutic approach to pediatric patients with acute chest syndrome: national multicenter survey of non invasive ventilation (NIV) and transfusion","volume":"28","author":"Heilbronner","year":"2021","journal-title":"Arch Pediatr Organe Off Soc Francaise Pediatr"},{"key":"10.1186\/s13613-025-01479-3_bb0795","doi-asserted-by":"crossref","first-page":"245","DOI":"10.23736\/S0375-9393.20.14972-1","article-title":"Non-invasive ventilation in pediatric acute chest syndrome: a preliminary two-center prospective observational study","volume":"87","author":"Idier","year":"2021","journal-title":"Minerva Anestesiol"},{"key":"10.1186\/s13613-025-01479-3_bb0800","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00043426-200011000-00009","article-title":"Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome","volume":"22","author":"Morris","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1186\/s13613-025-01479-3_bb0805","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/jama.2011.235","article-title":"Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial","volume":"305","author":"Gladwin","year":"2011","journal-title":"JAMA"},{"key":"10.1186\/s13613-025-01479-3_bb0810","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s00134-015-4060-2","article-title":"Inhaled nitric oxide for acute chest syndrome in adult sickle cell patients: a randomized controlled study","volume":"41","author":"Maitre","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1186\/s13613-025-01479-3_bb0815","first-page":"S99","article-title":"Pulmonary specific ancillary treatment for pediatric acute respiratory distress syndrome: from the second pediatric acute lung injury consensus conference","volume":"24","author":"Second Pediatric Acute Lung Injury Consensus Conference (PALICC-2) of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network","year":"2023","journal-title":"Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc"},{"key":"10.1186\/s13613-025-01479-3_bb0820","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12959-018-0179-z","article-title":"Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis","volume":"16","author":"Noubiap","year":"2018","journal-title":"Thromb J"},{"key":"10.1186\/s13613-025-01479-3_bb0825","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archinte.1979.03630380047016","article-title":"\u2019Acute Chest Syndrome\u2019in Adults With Sickle Cell Anemia: Microbiology, Treatment, and Prevention","volume":"139","author":"Charache","year":"1979","journal-title":"Arch Intern Med"},{"key":"10.1186\/s13613-025-01479-3_bb0830","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1160\/Th06-12-0718","article-title":"Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial","volume":"98","author":"Qari","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1186\/s13613-025-01479-3_bb0835","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s40814-020-00715-w","article-title":"Unfractionated heparin in acute chest syndrome: a pilot feasibility randomized controlled trial of unfractionated heparin vs. standard of care in acute chest syndrome","volume":"6","author":"Seaman","year":"2020","journal-title":"Pilot Feasibility Stud."},{"key":"10.1186\/s13613-025-01479-3_bb0840","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1182\/asheducation-2016.1.640","article-title":"Sickle cell disease: an inherited thrombophilia","volume":"2016","author":"Wun","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1186\/s13613-025-01479-3_bb0845","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12959-018-0179-z","article-title":"Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis","volume":"16","author":"Noubiap","year":"2018","journal-title":"Thromb J"},{"key":"10.1186\/s13613-025-01479-3_bb0850","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients","volume":"2","author":"Sch\u00fcnemann","year":"2018","journal-title":"Blood Adv"},{"key":"10.1186\/s13613-025-01479-3_bb0855","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2014.018","article-title":"Procalcitonin as a biomarker of bacterial infection in sickle cell vaso-occlusive crisis","volume":"6","author":"Patel","year":"2014","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1186\/s13613-025-01479-3_bb0860","first-page":"CR426","article-title":"Serum procalcitonin concentration as a negative predictor of serious bacterial infection in acute sickle cell pain crisis","volume":"9","author":"Scott","year":"2003","journal-title":"Med Sci Monit Int Med J Exp Clin Res."},{"key":"10.1186\/s13613-025-01479-3_bb0865","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s15010-010-0072-6","article-title":"Is procalcitonin a marker of invasive bacterial infection in acute sickle-cell vaso-occlusive crisis?","volume":"39","author":"Stankovic Stojanovic","year":"2011","journal-title":"Infection"},{"key":"10.1186\/s13613-025-01479-3_bb0870","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.3390\/jcm9113718","article-title":"Procalcitonin to reduce antibiotic exposure during acute chest syndrome in adult patients with sickle-cell disease","volume":"9","author":"Razazi","year":"2020","journal-title":"J Clin Med"},{"key":"10.1186\/s13613-025-01479-3_bb0875","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MPH.0b013e3182495573","article-title":"Procalcitonin is more useful than C-reactive protein in differentiation of fever in patients with sickle cell disease","volume":"34","author":"Unal","year":"2012","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1186\/s13613-025-01479-3_bb0880","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s12098-018-2717-x","article-title":"Does procalcitonin predict bacterial infection in febrile children with sickle cell disease?","volume":"86","author":"Elenga","year":"2019","journal-title":"Indian J Pediatr"},{"key":"10.1186\/s13613-025-01479-3_bb0885","doi-asserted-by":"crossref","first-page":"e27667","DOI":"10.1002\/pbc.27667","article-title":"Low-risk factors for severe bacterial infection and acute chest syndrome in children with sickle cell disease","volume":"66","author":"Rinc\u00f3n-L\u00f3pez","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"10.1186\/s13613-025-01479-3_bb0890","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3345\/kjp.2018.61.8.258","article-title":"Increased procalcitonin level is a risk factor for prolonged fever in children with Mycoplasma pneumonia","volume":"61","author":"Jeong","year":"2018","journal-title":"Korean J Pediatr"},{"key":"10.1186\/s13613-025-01479-3_bb0895","doi-asserted-by":"crossref","unstructured":"Mart\u00ed-Carvajal AJ, Conterno LO, Knight-Madden JM. Antibiotics for treating acute chest syndrome in people with sickle cell disease. In: The Cochrane Collaboration, editor. Cochrane Database Syst Rev [Internet]. Chichester, UK: John Wiley & Sons, Ltd; 2013 [cited 2016 May 15]. Available from: http:\/\/doi.wiley.com\/https:\/\/doi.org\/10.1002\/14651858.CD006110.pub3","DOI":"10.1002\/14651858.CD006110.pub3"},{"key":"10.1186\/s13613-025-01479-3_bb0900","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1038\/s41598-021-84163-3","article-title":"Infectious aetiologies of severe acute chest syndrome in sickle-cell adult patients, combining conventional microbiological tests and respiratory multiplex PCR","volume":"11","author":"Lopinto","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1186\/s13613-025-01479-3_bb0905","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.medmal.2019.04.391","article-title":"Molecular testing for respiratory pathogens in sickle cell disease adult patients presenting with febrile acute chest syndrome","volume":"50","author":"Raffetin","year":"2019","journal-title":"M\u00e9decine Mal Infect."},{"key":"10.1186\/s13613-025-01479-3_bb0910","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/pbc.24798","article-title":"Prospective evaluation for respiratory pathogens in children with sickle cell disease and acute respiratory illness","volume":"61","author":"Srinivasan","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1186\/s13613-025-01479-3_bb0915","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/archdischild-2019-317315","article-title":"Respiratory pathogens and acute chest syndrome in children with sickle cell disease","volume":"105","author":"Ploton","year":"2020","journal-title":"Arch Dis Child"},{"key":"10.1186\/s13613-025-01479-3_bb0920","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.25141","article-title":"Incidence of acute chest syndrome in children with sickle cell disease following implementation of the 13-valent pneumococcal conjugate vaccine in France","volume":"5","author":"Assad","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1186\/s13613-025-01479-3_bb0925","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00043426-200301000-00010","article-title":"Chlamydia pneumoniae and acute chest syndrome in patients with sickle cell disease","volume":"25","author":"Dean","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1186\/s13613-025-01479-3_bb0930","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1542\/peds.112.1.87","article-title":"Mycoplasma disease and acute chest syndrome in sickle cell disease","volume":"112","author":"Neumayr","year":"2003","journal-title":"Pediatrics"},{"key":"10.1186\/s13613-025-01479-3_bb0935","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/jamapediatrics.2017.2526","article-title":"Association of guideline-adherent antibiotic treatment with readmission of children with sickle cell disease hospitalized with acute chest syndrome","volume":"171","author":"Bundy","year":"2017","journal-title":"JAMA Pediatr"},{"key":"10.1186\/s13613-025-01479-3_bb0940","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.annemergmed.2020.08.011","article-title":"Association of antibiotic choice with hospital length of stay and risk factors for readmission in patients with sickle cell disease and acute chest syndrome: an observational cohort study","volume":"76","author":"Badaki-Makun","year":"2020","journal-title":"Ann Emerg Med"},{"key":"10.1186\/s13613-025-01479-3_bb0945","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13054-019-2378-9","volume":"23","author":"Guilhaumou","year":"2019","journal-title":"Crit Care Lond Engl"},{"key":"10.1186\/s13613-025-01479-3_bb0950","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2215\/CJN.08511109","article-title":"Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature","volume":"5","author":"Haymann","year":"2010","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"10.1186\/s13613-025-01479-3_bb0955","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1007\/s00467-010-1736-2","article-title":"Sickle cell nephropathy: challenging the conventional wisdom","volume":"26","author":"Becker","year":"2011","journal-title":"Pediatr Nephrol Berl Ger"},{"key":"10.1186\/s13613-025-01479-3_bb0960","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.jiac.2022.05.017","article-title":"Suboptimal vancomycin levels in critically ill children with sickle cell disease and acute chest syndrome","volume":"28","author":"Al-Eyadhy","year":"2022","journal-title":"J Infect Chemother Off J Jpn Soc Chemother"},{"key":"10.1186\/s13613-025-01479-3_bb0965","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2369-13-83","article-title":"Determination of the best method to estimate glomerular filtration rate from serum creatinine in adult patients with sickle cell disease: a prospective observational cohort study","volume":"13","author":"Arlet","year":"2012","journal-title":"BMC Nephrol"},{"key":"10.1186\/s13613-025-01479-3_bb0970","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1093\/jac\/dky312","article-title":"Profound underdosing of \u03b2-lactams in patients with sickle-cell disease","volume":"73","author":"Cecchini","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1186\/s13613-025-01479-3_bb0975","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0302298","article-title":"Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome","volume":"19","author":"Razazi","year":"2024","journal-title":"PLoS ONE"},{"key":"10.1186\/s13613-025-01479-3_bb0980","first-page":"441","article-title":"Continuous versus intermittent infusion of cefotaxime in critically ill patients: a randomized controlled trial comparing plasma concentrations","volume":"75","author":"Aardema","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1186\/s13613-025-01479-3_bb0985","doi-asserted-by":"crossref","first-page":"e00637","DOI":"10.1128\/AAC.00637-17","article-title":"Population pharmacokinetics of cefotaxime and dosage recommendations in children with sickle cell disease","volume":"62","author":"Maksoud","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1186\/s13613-025-01479-3_bb0990","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s40262-017-0602-9","article-title":"Population pharmacokinetic model to optimize cefotaxime dosing regimen in critically Ill children","volume":"57","author":"B\u00e9ranger","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"10.1186\/s13613-025-01479-3_bb0995","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/vox.12990","article-title":"Automated RBC Exchange has a greater effect on whole blood viscosity than manual whole blood exchange in adult patients with sickle cell disease","volume":"115","author":"Ait Abdallah","year":"2020","journal-title":"Vox Sang"},{"key":"10.1186\/s13613-025-01479-3_bb1000","doi-asserted-by":"crossref","first-page":"727","DOI":"10.20344\/amp.8228","article-title":"Partial red blood cell exchange in children and young patients with sickle cell disease: manual versus automated procedure","volume":"30","author":"Escobar","year":"2017","journal-title":"Acta Med Port"},{"key":"10.1186\/s13613-025-01479-3_bb1005","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1007\/s00277-020-04188-y","article-title":"Manual erythroexchange in sickle cell disease: multicenter validation of a protocol predictive of volume to exchange and hemoglobin values","volume":"99","author":"Gianesin","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1186\/s13613-025-01479-3_bb1010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/bjh.13294","article-title":"A comparison of chronic manual and automated red blood cell exchange transfusion in sickle cell disease patients","volume":"170","author":"Kuo","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1186\/s13613-025-01479-3_bb1015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ajh.20054","article-title":"Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome","volume":"76","author":"Liem","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1186\/s13613-025-01479-3_bb1020","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.743483","article-title":"Priming With red blood cells allows red blood cell exchange for sickle cell disease in low-weight children","volume":"8","author":"Hequet","year":"2021","journal-title":"Front Med"},{"key":"10.1186\/s13613-025-01479-3_bb1025","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/trf.13548","article-title":"Comparison of automated erythrocytapheresis versus manual exchange transfusion to treat cerebral macrovasculopathy in sickle cell anemia","volume":"56","author":"Koehl","year":"2016","journal-title":"Transfusion (Paris)"},{"key":"10.1186\/s13613-025-01479-3_bb1030","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/jca.21511","article-title":"Red blood cell exchange: 2015 American Society for Apheresis consensus conference on the management of patients with sickle cell disease","volume":"32","author":"Sarode","year":"2017","journal-title":"J Clin Apheresis"},{"key":"10.1186\/s13613-025-01479-3_bb1035","doi-asserted-by":"crossref","first-page":"3518402","DOI":"10.1155\/2017\/3518402","article-title":"Efficacy and safety of manual partial red cell exchange in the management of severe complications of sickle cell disease in a developing country","volume":"2017","author":"Faye","year":"2017","journal-title":"Adv Hematol"},{"key":"10.1186\/s13613-025-01479-3_bb1040","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/trf.14575","article-title":"Automated RBC exchange compared to manual exchange transfusion for children with sickle cell disease is cost-effective and reduces iron overload","volume":"58","author":"Dedeken","year":"2018","journal-title":"Transfusion (Paris)"},{"key":"10.1186\/s13613-025-01479-3_bb1045","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s40258-016-0302-x","article-title":"Spectra Optia\u00ae for automated red blood cell exchange in patients with sickle cell disease: a NICE medical technology guidance","volume":"15","author":"Willits","year":"2017","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1186\/s13613-025-01479-3_bb1050","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/pbc.22211","article-title":"Erythrocytapheresis in children with sickle cell disease and acute chest syndrome","volume":"53","author":"Velasquez","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1186\/s13613-025-01479-3_bb1055","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jpeds.2012.09.009","article-title":"Short-term femoral catheter insertion: a promising alternative to consistently allow long-term erythrocytapheresis therapy in children with sickle cell anemia","volume":"162","author":"Billard","year":"2013","journal-title":"J Pediatr"},{"key":"10.1186\/s13613-025-01479-3_bb1060","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1067\/mpd.2001.119593","article-title":"Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia","volume":"139","author":"Miller","year":"2001","journal-title":"J Pediatr"},{"key":"10.1186\/s13613-025-01479-3_bb1065","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/bjh.13390","article-title":"A pilot randomized trial of red blood cell transfusion for acute treatment of vaso-occlusive pain episodes in sickle cell anaemia","volume":"171","author":"Kelly","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1186\/s13613-025-01479-3_bb1070","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1182\/hematology.2021000307","article-title":"Indications for transfusion in the management of sickle cell disease","volume":"2021","author":"Han","year":"2021","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1186\/s13613-025-01479-3_bb1075","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/bjh.15115","article-title":"How I manage red cell transfusions in patients with sickle cell disease","volume":"180","author":"Rees","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1186\/s13613-025-01479-3_bb1080","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ppul.23367","article-title":"Longitudinal assessment of lung function in children with sickle cell disease","volume":"51","author":"Lunt","year":"2016","journal-title":"Pediatr Pulmonol"},{"key":"10.1186\/s13613-025-01479-3_bb1085","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/0885066620978770","article-title":"Hemoglobin target and transfusion modality for adult patients with sickle cell disease acute chest syndrome","volume":"37","author":"Simonson","year":"2022","journal-title":"J Intensive Care Med"},{"key":"10.1186\/s13613-025-01479-3_bb1090","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1111\/trf.13155","article-title":"Blood transfusion and 30-day readmission rate in adult patients hospitalized with sickle cell disease crisis","volume":"55","author":"Nouraie","year":"2015","journal-title":"Transfusion (Paris)"},{"key":"10.1186\/s13613-025-01479-3_bb1095","first-page":"CD007843","article-title":"Blood transfusions for treating acute chest syndrome in people with sickle cell disease","volume":"1","author":"Dolatkhah","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1186\/s13613-025-01479-3_bb1100","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jpeds.2006.06.037","article-title":"Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemia","volume":"149","author":"Hulbert","year":"2006","journal-title":"J Pediatr"},{"key":"10.1186\/s13613-025-01479-3_bb1105","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/bjh.14383","article-title":"Guidelines on red cell transfusion in sickle cell disease Part II: indications for transfusion","volume":"176","author":"Davis","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1186\/s13613-025-01479-3_bb1110","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1182\/bloodadvances.2019001142","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults","volume":"4","author":"DeBaun","year":"2020","journal-title":"Blood Adv"},{"key":"10.1186\/s13613-025-01479-3_bb1115","first-page":"128","article-title":"Recommendations for the use of red blood cell exchange in sickle cell disease","volume":"58","author":"Fort","year":"2019","journal-title":"Transfus Apher Sci Off J World Apher Assoc Off J Eur Soc Haemapheresis"},{"key":"10.1186\/s13613-025-01479-3_bb1120","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/adc.56.10.765","article-title":"Acute splenic sequestration and hypersplenism in the first five years in homozygous sickle cell disease","volume":"56","author":"Topley","year":"1981","journal-title":"Arch Dis Child"},{"key":"10.1186\/s13613-025-01479-3_bb1125","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2141.2011.08999.x","article-title":"Acute splenic sequestration crisis in sickle cell disease: cohort study of 190 paediatric patients: acute splenic sequestration crisis in sickle cell disease","volume":"156","author":"Brousse","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1186\/s13613-025-01479-3_bb1130","first-page":"CD010985","article-title":"Interventions for treating intrahepatic cholestasis in people with sickle cell disease","volume":"7","author":"Mart\u00ed-Carvajal","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1186\/s13613-025-01479-3_bb1135","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1001\/archinte.1980.00330210112034","article-title":"Exchange transfusion for sickle cell intrahepatic cholestasis","volume":"140","author":"Sheehy","year":"1980","journal-title":"Arch Intern Med"},{"key":"10.1186\/s13613-025-01479-3_bb1140","first-page":"256","article-title":"Do automated red cell exchanges relieve priapism in patients with sickle cell anemia?","volume":"4","author":"McCarthy","year":"2000","journal-title":"Ther Apher Off J Int Soc Apher Jpn Soc Apher"},{"key":"10.1186\/s13613-025-01479-3_bb1145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jca.21394","article-title":"Safety and efficacy of blood exchange transfusion for priapism complicating sickle cell disease","volume":"31","author":"Ballas","year":"2016","journal-title":"J Clin Apheresis"},{"key":"10.1186\/s13613-025-01479-3_bb1150","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0022-5347(17)35817-2","article-title":"Association of sickle cell disease, priapism, exchange transfusion and neurological events: ASPEN syndrome","volume":"150","author":"Siegel","year":"1993","journal-title":"J Urol"},{"key":"10.1186\/s13613-025-01479-3_bb1155","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2141.2011.08999.x","article-title":"Acute splenic sequestration crisis in sickle cell disease: cohort study of 190 paediatric patients","volume":"156","author":"Brousse","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1186\/s13613-025-01479-3_bb1160","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.24460","article-title":"Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes: DHTR in SCD Patients","author":"Habibi","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1186\/s13613-025-01479-3_bb1165","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2018-02-785964","article-title":"How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions","volume":"131","author":"Pirenne","year":"2018","journal-title":"Blood"},{"key":"10.1186\/s13613-025-01479-3_bb1170","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3324\/haematol.2022.281050","article-title":"Delayed hemolytic transfusion reaction in children with sickle cell disease: first 5-year retrospective study in mainland France","volume":"108","author":"Falgui\u00e8re","year":"2023","journal-title":"Haematologica"},{"key":"10.1186\/s13613-025-01479-3_bb1175","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/bjh.18605","article-title":"Delayed haemolytic transfusion reaction in paediatric patients with sickle cell disease: a retrospective study in a French national reference centre","volume":"201","author":"Rossi","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1186\/s13613-025-01479-3_bb1180","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1046\/j.1537-2995.1997.37497265338.x","article-title":"The sickle cell hemolytic transfusion reaction syndrome","volume":"37","author":"Petz","year":"1997","journal-title":"Transfusion (Paris)"},{"key":"10.1186\/s13613-025-01479-3_bb1185","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/ajh.24537","article-title":"A diagnostic nomogram for delayed hemolytic transfusion reaction in sickle cell disease","volume":"91","author":"Mekontso Dessap","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1186\/s13613-025-01479-3_bb1190","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1182\/blood-2019-130874","article-title":"Rituximab for preventing delayed hemolytic transfusion reaction (DHTR) in sickle cell adult patients: outcome of transfusion and side effects in 58 cases","volume":"134","author":"Zanchetta-Balint","year":"2019","journal-title":"Blood"},{"key":"10.1186\/s13613-025-01479-3_bb1195","article-title":"Can we better predict delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease?","volume":"59","author":"Adkins","year":"2020","journal-title":"Transfus Apher Sci Off J World Apher Assoc Off J Eur Soc Haemapheresis"},{"issue":"12","key":"10.1186\/s13613-025-01479-3_bb1200","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/ajh.24908","article-title":"Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease","volume":"92","author":"Narbey","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1186\/s13613-025-01479-3_bb1205","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3324\/haematol.2019.224709","article-title":"Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal","volume":"105","author":"Thein","year":"2020","journal-title":"Haematologica"},{"key":"10.1186\/s13613-025-01479-3_bb1210","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.revmed.2014.11.015","article-title":"Delayed haemolytic transfusion reaction: about 3\u00a0patients with sickle cell disease","volume":"36","author":"Bertrand","year":"2015","journal-title":"Rev Med Interne"},{"key":"10.1186\/s13613-025-01479-3_bb1215","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.tmrv.2015.06.001","article-title":"Hyperhemolysis in patients with hemoglobinopathies: a single-center experience and review of the literature","volume":"29","author":"Danaee","year":"2015","journal-title":"Transfus Med Rev"},{"key":"10.1186\/s13613-025-01479-3_bb1220","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/bjh.17875","article-title":"Extended phenotyping does not preclude the occurrence of delayed haemolytic transfusion reactions in sickle cell disease","volume":"196","author":"Gerritsma","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1186\/s13613-025-01479-3_bb1225","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5694\/j.1326-5377.2010.tb03509.x","article-title":"Hyperhaemolysis in sickle cell disease\u2013an unusual and potentially life-threatening complication","volume":"192","author":"Stokes","year":"2010","journal-title":"Med J Aust"},{"key":"10.1186\/s13613-025-01479-3_bb1230","first-page":"CD004198","article-title":"Treatments for priapism in boys and men with sickle cell disease","volume":"4","author":"Chinegwundoh","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1186\/s13613-025-01479-3_bb1235","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/JU.0000000000002236","article-title":"Acute ischemic priapism: an AUA\/SMSNA guideline","volume":"206","author":"Bivalacqua","year":"2021","journal-title":"J Urol"},{"key":"10.1186\/s13613-025-01479-3_bb1240","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/01.ju.0000087608.07371.ca","article-title":"American Urological Association guideline on the management of priapism","volume":"170","author":"Montague","year":"2003","journal-title":"J Urol"},{"key":"10.1186\/s13613-025-01479-3_bb1245","first-page":"392","article-title":"Prise en charge du priapisme chez les patients dr\u00e9panocytaires","volume":"15","author":"Roupret","year":"2005","journal-title":"Prog En Urol."},{"key":"10.1186\/s13613-025-01479-3_bb1250","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2013.11.008","article-title":"European Association of Urology guidelines on priapism","volume":"65","author":"Salonia","year":"2014","journal-title":"Eur Urol"},{"key":"10.1186\/s13613-025-01479-3_bb1255","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1743-6109.2009.01625.x","article-title":"Priapism: pathogenesis, epidemiology, and management","volume":"7","author":"Broderick","year":"2010","journal-title":"J Sex Med"},{"key":"10.1186\/s13613-025-01479-3_bb1260","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.purol.2018.07.281","article-title":"Le priapisme : diagnostic et prise en charge","volume":"28","author":"Carnicelli","year":"2018","journal-title":"Prog En Urol"},{"key":"10.1186\/s13613-025-01479-3_bb1265","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1743-6109.2011.02287.x","article-title":"Priapism in sickle-cell disease: a hematologist\u2019s perspective","volume":"9","author":"Kato","year":"2012","journal-title":"J Sex Med"},{"key":"10.1186\/s13613-025-01479-3_bb1270","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.hoc.2005.08.003","article-title":"Priapism in sickle cell disease","volume":"19","author":"Rogers","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1186\/s13613-025-01479-3_bb1275","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1743-6109.2011.02317.x","article-title":"Priapism and sickle-cell anemia: diagnosis and nonsurgical therapy","volume":"9","author":"Broderick","year":"2012","journal-title":"J Sex Med"},{"key":"10.1186\/s13613-025-01479-3_bb1280","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jemermed.2016.05.042","article-title":"Emergency medicine management of sickle cell disease complications: an evidence-based update","volume":"51","author":"Simon","year":"2016","journal-title":"J Emerg Med"},{"key":"10.1186\/s13613-025-01479-3_bb1285","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1743-6109.2008.00770.x","article-title":"Sickle cell disease status and outcomes of African-American men presenting with priapism","volume":"5","author":"Bennett","year":"2008","journal-title":"J Sex Med"},{"key":"10.1186\/s13613-025-01479-3_bb1290","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1182\/blood.V95.1.78","article-title":"Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism","volume":"95","author":"Mantadakis","year":"2000","journal-title":"Blood"},{"key":"10.1186\/s13613-025-01479-3_bb1295","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ajem.2015.10.029","article-title":"Effect of phenylephrine and terbutaline on ischemic priapism: a retrospective review","volume":"34","author":"Martin","year":"2016","journal-title":"Am J Emerg Med"},{"key":"10.1186\/s13613-025-01479-3_bb1300","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/JU.0000000000001183","article-title":"Using artificial intelligence to predict surgical shunts in men with ischemic priapism","volume":"204","author":"Masterson","year":"2020","journal-title":"J Urol"},{"key":"10.1186\/s13613-025-01479-3_bb1305","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1182\/hematology.2022000380","article-title":"Epidemiology and treatment of priapism in sickle cell disease","volume":"2022","author":"Idris","year":"2022","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1186\/s13613-025-01479-3_bb1310","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jpurol.2013.07.024","article-title":"Priapism in children: a comprehensive review and clinical guideline","volume":"10","author":"Donaldson","year":"2014","journal-title":"J Pediatr Urol"},{"key":"10.1186\/s13613-025-01479-3_bb1315","first-page":"194","article-title":"Priapism in children: review of pathophysiology and treatment","volume":"85","author":"de Jesus","year":"2009","journal-title":"J Pediatr (Rio J)"},{"key":"10.1186\/s13613-025-01479-3_bb1320","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.urology.2015.11.023","article-title":"Trends in sickle cell disease-related priapism in U.S. children\u2019s hospitals","volume":"89","author":"Wang","year":"2016","journal-title":"Urology"},{"key":"10.1186\/s13613-025-01479-3_bb1325","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nrurol.2014.9","article-title":"Sexual dysfunction: first EAU priapism treatment guidelines published","volume":"11","author":"Albersen","year":"2014","journal-title":"Nat Rev Urol"},{"key":"10.1186\/s13613-025-01479-3_bb1330","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/adc.85.1.52","article-title":"Management of sickle cell priapism with etilefrine","volume":"85","author":"Gbado\u00e9","year":"2001","journal-title":"Arch Dis Child"},{"key":"10.1186\/s13613-025-01479-3_bb1335","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2164\/jandrol.110.010934","article-title":"A prospective diary study of stuttering priapism in adolescents and young men with sickle cell anemia: report of an international randomized control trial\u2013the priapism in sickle cell study","volume":"32","author":"Olujohungbe","year":"2011","journal-title":"J Androl"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-025-01479-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13613-025-01479-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025000688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025000688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-025-01479-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:49:49Z","timestamp":1776671389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582025000688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":266,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"alternative-id":["S2110582025000688"],"URL":"https:\/\/doi.org\/10.1186\/s13613-025-01479-3","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guidelines for the management of emergencies and critical illness in pediatric and adult patients with sickle cell disease","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s13613-025-01479-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025 The Author(s) 2025. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}],"article-number":"74"}}